» Articles » PMID: 28193005

Mapping the Energetic Epitope of an Antibody/Interleukin-23 Interaction with Hydrogen/Deuterium Exchange, Fast Photochemical Oxidation of Proteins Mass Spectrometry, and Alanine Shave Mutagenesis

Abstract

Epitope mapping the specific residues of an antibody/antigen interaction can be used to support mechanistic interpretation, antibody optimization, and epitope novelty assessment. Thus, there is a strong need for mapping methods, particularly integrative ones. Here, we report the identification of an energetic epitope by determining the interfacial hot-spot that dominates the binding affinity for an anti-interleukin-23 (anti-IL-23) antibody by using the complementary approaches of hydrogen/deuterium exchange mass spectrometry (HDX-MS), fast photochemical oxidation of proteins (FPOP), alanine shave mutagenesis, and binding analytics. Five peptide regions on IL-23 with reduced backbone amide solvent accessibility upon antibody binding were identified by HDX-MS, and five different peptides over the same three regions were identified by FPOP. In addition, FPOP analysis at the residue level reveals potentially key interacting residues. Mutants with 3-5 residues changed to alanine have no measurable differences from wild-type IL-23 except for binding of and signaling blockade by the 7B7 anti-IL-23 antibody. The M5 IL-23 mutant differs from wild-type by five alanine substitutions and represents the dominant energetic epitope of 7B7. M5 shows a dramatic decrease in binding to BMS-986010 (which contains the 7B7 Fab, where Fab is fragment antigen-binding region of an antibody), yet it maintains functional activity, binding to p40 and p19 specific reagents, and maintains biophysical properties similar to wild-type IL-23 (monomeric state, thermal stability, and secondary structural features).

Citing Articles

Covalent Labeling Automated Data Analysis Platform for High Throughput in R (coADAPTr): A Proteome-Wide Data Analysis Platform for Covalent Labeling Experiments.

Shortt R, Pino L, Chea E, Ramirez C, Polasky D, Nesvizhskii A J Am Soc Mass Spectrom. 2024; 35(12):3301-3307.

PMID: 39356573 PMC: 11622367. DOI: 10.1021/jasms.4c00196.


Mapping conformational changes on bispecific antigen-binding biotherapeutic by covalent labeling and mass spectrometry.

Shah A, Batabyal D, Qiu D, Cui W, Harrahy J, Ivanov A J Pharm Anal. 2024; 14(8):100966.

PMID: 39263356 PMC: 11388688. DOI: 10.1016/j.jpha.2024.100966.


Characterization of Higher Order Structural Changes of a Thermally Stressed Monoclonal Antibody via Mass Spectrometry Footprinting and Other Biophysical Approaches.

Lin Y, Moyle A, Beaumont V, Liu L, Polleck S, Liu H Anal Chem. 2023; 95(46):16840-16849.

PMID: 37933954 PMC: 10909587. DOI: 10.1021/acs.analchem.3c02422.


Hydrogen Deuterium Exchange and other Mass Spectrometry-based Approaches for Epitope Mapping.

Jethva P, Gross M Front Anal Sci. 2023; 3.

PMID: 37746528 PMC: 10512744. DOI: 10.3389/frans.2023.1118749.


Structural Investigation of Therapeutic Antibodies Using Hydroxyl Radical Protein Footprinting Methods.

Ralston C, Sharp J Antibodies (Basel). 2022; 11(4).

PMID: 36412837 PMC: 9680451. DOI: 10.3390/antib11040071.


References
1.
Novotny J, Bruccoleri R, Davis M, Sharp K . Empirical free energy calculations: a blind test and further improvements to the method. J Mol Biol. 1997; 268(2):401-11. DOI: 10.1006/jmbi.1997.0961. View

2.
Wells J . Systematic mutational analyses of protein-protein interfaces. Methods Enzymol. 1991; 202:390-411. DOI: 10.1016/0076-6879(91)02020-a. View

3.
Lankford C, Frucht D . A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol. 2003; 73(1):49-56. DOI: 10.1189/jlb.0602326. View

4.
Tang C, Chen S, Qian H, Huang W . Interleukin-23: as a drug target for autoimmune inflammatory diseases. Immunology. 2011; 135(2):112-24. PMC: 3277713. DOI: 10.1111/j.1365-2567.2011.03522.x. View

5.
Di Cesare A, Di Meglio P, Nestle F . The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 2009; 129(6):1339-50. DOI: 10.1038/jid.2009.59. View